Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JW.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JW.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JW.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.3.18ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.3.18ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.18NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBC.1.6.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBC.1.6.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.1.6.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.6.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.39ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.39ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.39ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.39NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.141ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.141ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.141ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.141NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.591ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.591ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.591ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.591NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.468ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.468ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.468ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.468NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.131 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.131 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.131 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.131 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.586ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.586ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.586ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.586NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.366ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.366ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.366ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.366NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.380ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.380ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.380ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.380NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.148ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.148ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.148ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.148NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.382ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.382ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.382ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used